The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer’s and Parkinson’s disease
Open accessAbstract
It has been well established that neuronal loss within the cholinergic nucleus basalis of Meynert (nbM) correlates with cognitive decline in dementing disorders such as Alzheimer's disease (AD). Friedrich Lewy first observed his eponymous inclusion bodies in the nbM of postmortem brain tissue from patients with Parkinson's disease (PD) and cell loss in this area can be at least as extensive as that seen in AD. There has been confusion with regard to the terminology and exact localisation of the nbM within the human basal forebrain for decades due to the diffuse and broad structure of this "nucleus". Also, while topographical projections from the nbM have been mapped out in subhuman primates, no direct clinicopathological correlations between subregional nbM and cortical pathology and specific cognitive profile decline have been performed in human tissue. Here, we review the evolution of the term nbM and the importance of standardised nbM sampling for neuropathological studies. Extensive review of the literature suggests that there is a caudorostral pattern of neuronal loss within the nbM in AD brains. However, the findings in PD are less clear due to the limited number of studies performed. Given the differing neuropsychiatric and cognitive deficits in Lewy body-associated dementias (PD dementia and dementia with Lewy bodies) as compared to AD, we hypothesise that a different pattern of neuronal loss will be found in the nbM of Lewy body disease brains. Understanding the functional significance of the subregions of the nbM could prove important in elucidating the pathogenesis of dementia in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Parkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 881
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
Irwin, D. J., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3549 · Cited by 869
Arendt, T., Bigl, V., Arendt, A., & Tennstedt, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697388 · Cited by 817
Prion-like transmission of protein aggregates in neurodegenerative diseases
Brundin, P., Melki, R., & Kopito, R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2873 · Cited by 778
Prion-like mechanisms in neurodegenerative diseases
Frost, B., & Diamond, M. I. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2786 · Cited by 776
Arriagada, P. V., Marzloff, K., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.9.1681 · Cited by 638
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe
Harding, A. J., Broe, G. A., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf033 · Cited by 609
Mesulam, M.-M., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90163-5 · Cited by 596
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Compta, Y., Parkkinen, L., O'Sullivan, S. S., Vandrovcova, J., Holton, J. L., Collins, C., Lashley, T., Kallis, C., Williams, D. R., de Silva, R., et al. (2011) · Brain · doi:10.1093/brain/awr031 · Cited by 583
Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2013) · Neurodegenerative Diseases · doi:10.1159/000341998 · Cited by 573
Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E., & Perry, R. H. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.413 · Cited by 571
Bohnen, N. I., Kaufer, D. I., Ivanco, L. S., Lopresti, B., Koeppe, R. A., Davis, J. G., Mathis, C. A., Moore, R. Y., & DeKosky, S. T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1745 · Cited by 551
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Mesulam, M., & Geula, C. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902750205 · Cited by 518
Divac, I. (1975) · Brain Research · doi:10.1016/0006-8993(75)90178-x · Cited by 488
Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases
Candy, J. M., Perry, R. H., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F., & Tomlinson, B. E. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90045-x · Cited by 459
Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain
McGeer, P. L., McGeer, E. G., Suzuki, J., Dolman, C. E., & Nagai, T. (1984) · Neurology · doi:10.1212/wnl.34.6.741 · Cited by 457
Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex
Mesulam, M.-M., & Van Hoesen, G. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90385-1 · Cited by 426
Kuhl, D. E., Minoshima, S., Fessler, J. A., Ficaro, E. P., Wieland, D. M., Koeppe, R. A., Frey, K. A., & Foster, N. L. (1996) · Annals of Neurology · doi:10.1002/ana.410400309 · Cited by 426
Arendt, T., Bigl, V., Tennstedt, A., & Arendt, A. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90160-5 · Cited by 410
History of falls in Parkinson disease is associated with reduced cholinergic activity
Bohnen, N. I., Müller, M. L. T. M., Koeppe, R. A., Studenski, S. A., Kilbourn, M. A., Frey, K. A., & Albin, R. L. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c1ded6 · Cited by 409
Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain
Zaborszky, L., Hoemke, L., Mohlberg, H., Schleicher, A., Amunts, K., & Zilles, K. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.05.055 · Cited by 393
Basal Forebrain and Hypothalamic Connection to Frontal and Parietal Cortex in the Rhesus Monkey
Kievit, J., & Kuypers, H. G. J. M. (1975) · Science · doi:10.1126/science.1114317 · Cited by 384
Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways
Hilker, R., Thomas, A. V., Klein, J. C., Weisenbach, S., Kalbe, E., Burghaus, L., Jacobs, A. H., Herholz, K., & Heiss, W. D. (2005) · Neurology · doi:10.1212/01.wnl.0000191154.78131.f6 · Cited by 384
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET
Shimada, H., Hirano, S., Shinotoh, H., Aotsuka, A., Sato, K., Tanaka, N., Ota, T., Asahina, M., Fukushi, K., Kuwabara, S., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ab2b58 · Cited by 366
Bohnen, N. I., Kaufer, D. I., Hendrickson, R., Ivanco, L. S., Lopresti, B. J., Constantine, G. M., Mathis, C. A., Davis, J. G., Moore, R. Y., & DeKosky, S. T. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0971-0 · Cited by 364
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo
Klein, J. C., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., Vollmar, S., Baudrexel, S., Diederich, N. J., Heiss, W. D., & Hilker, R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d55f61 · Cited by 356
MANN, D. M. A., YATES, P. O., & MARCYNIUK, B. (1984) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1984.tb00351.x · Cited by 345
Pearson, R. C. A., Sofroniew, M. V., Cuello, A. C., Powell, T. P. S., Eckenstein, F., Esiri, M. M., & Wilcock, G. K. (1983) · Brain Research · doi:10.1016/0006-8993(83)90046-x · Cited by 334
Arendt, T., Schindler, C., Brückner, M. K., Eschrich, K., Bigl, V., Zedlick, D., & Marcova, L. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00516.1997 · Cited by 319
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
Bohnen, N. I., Muller, M. L. T. M., Kotagal, V., Koeppe, R. A., Kilbourn, M. A., Albin, R. L., & Frey, K. A. (2010) · Brain · doi:10.1093/brain/awq079 · Cited by 316
Parkinson's Disease: The Dual Hit Theory Revisited
Hawkes, C. H., Del Tredici, K., & Braak, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04365.x · Cited by 303
Hall, H., Reyes, S., Landeck, N., Bye, C., Leanza, G., Double, K., Thompson, L., Halliday, G., & Kirik, D. (2014) · Brain · doi:10.1093/brain/awu193 · Cited by 302
Mufson, E. J., Bothwell, M., & Kordower, J. H. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90124-6 · Cited by 279
Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease
Vogels, O. J. M., Broere, C. A. J., Ter Laak, H. J., Ten Donkelaar, H. J., Nieuwenhuys, R., & Schulte, B. P. M. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90056-6 · Cited by 279
Dementia in idiopathic Parkinson's disease: A neuropathological study of 32 cases
Gaspar, P., & Gray, F. (1984) · Acta Neuropathologica · doi:10.1007/bf00695605 · Cited by 275
Chan‐Palay, V. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902730409 · Cited by 273
Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia
Kuhn, J., Hardenacke, K., Lenartz, D., Gruendler, T., Ullsperger, M., Bartsch, C., Mai, J. K., Zilles, K., Bauer, A., Matusch, A., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.32 · Cited by 262
Schaltenbrand, G., Bailey, P., & Akert, A. (1959) · Thieme eBooks · Cited by 260
Parkinson's disease: Neuron loss in the nucleus basalis without concomitant Alzheimer's disease
Nakano, I., & Hirano, A. (1984) · Annals of Neurology · doi:10.1002/ana.410150503 · Cited by 259
Are synucleinopathies prion-like disorders?
Angot, E., Steiner, J. A., Hansen, C., Li, J.-Y., & Brundin, P. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70213-1 · Cited by 251
Perry, R. H., Candy, J. M., Perry, E. K., Irving, D., Blessed, G., & Fairbairn, A. D. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90391-3 · Cited by 240
Subregional Basal Forebrain Atrophy in Alzheimer's Disease: A Multicenter Study
Kilimann, I., Grothe, M., Heinsen, H., Alho, E. J. L., Grinberg, L., Amaro Jr., E., dos Santos, G. A. B., da Silva, R. E., Mitchell, A. J., Frisoni, G. B., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132345 · Cited by 232
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease
Rafii, M. S., Baumann, T. L., Bakay, R. A. E., Ostrove, J. M., Siffert, J., Fleisher, A. S., Herzog, C. D., Barba, D., Pay, M., Salmon, D. P., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.09.004 · Cited by 223
Perry, E. K., Irving, D., Kerwin, J. M., McKeith, I. G., Thompson, P., Collerton, D., Fairbairn, A. F., Ince, P. G., Morris, C. M., Cheng, A. V., et al. (1993) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199307020-00002 · Cited by 214
Etienne, P., Robitaille, Y., Wood, P., Gauthier, S., Nair, N. P. V., & Quirion, R. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90142-9 · Cited by 213
Nagai, T., McGeer, P. L., Peng, J. H., McGeer, E. G., & Dolman, C. E. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90264-1 · Cited by 209
Lehéricy, S., Hirsch, É. C., Cervera‐Piérot, P., Hersh, L. B., Bakchine, S., Piette, F., Duyckaerts, C., Hauw, J., Javoy‐Agid, F., & Agid, Y. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903300103 · Cited by 207
Abnormalities of the nucleus basalis in Down's syndrome
Casanova, M. F., Walker, L. C., Whitehouse, P. J., & Price, D. L. (1985) · Annals of Neurology · doi:10.1002/ana.410180306 · Cited by 201
The nucleus basalis of Meynert in neurological disease: A quantitative morphological study
Rogers, J. D., Brogan, D., & Mirra, S. S. (1985) · Annals of Neurology · doi:10.1002/ana.410170210 · Cited by 200
Role of Cholinesterase Inhibitors in Parkinson’s Disease and dementia with Lewy Bodies
Aarsland, D., Mosimann, U. P., & McKeith, I. G. (2004) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704267463 · Cited by 180
STUDIES ON THE COMPARATIVE ANATOMY OF THE GANGLION BASALE OF MEYNERT
Gorry, J. D. (1963) · Cells Tissues Organs · doi:10.1159/000142464 · Cited by 171
THE NUCLEUS BASALIS IN ALZHEIMER'S DISEASE: CELL COUNTS AND CORTICAL BIOCHEMISTRY
Wilcock, G. K., Esiri, M. M., Bowen, D. M., & SMITHS, C. C. T. (1983) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1983.tb00105.x · Cited by 164
Mufson, E. J., Cochran, E., Benzing, W., & Kordower, J. H. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107329 · Cited by 162
González-Redondo, R., García-García, D., Clavero, P., Gasca-Salas, C., García-Eulate, R., Zubieta, J. L., Arbizu, J., Obeso, J. A., & Rodríguez-Oroz, M. C. (2014) · Brain · doi:10.1093/brain/awu159 · Cited by 162
The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?
Gratwicke, J., Kahan, J., Zrinzo, L. U., Hariz, M. I., Limousin, P. D., Foltynie, T., & Jahanshahi, M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.003 · Cited by 162
Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
Jellinger, K. A., & Attems, J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0088-2 · Cited by 158
Challenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154
Striatal β-Amyloid Deposition in Parkinson Disease With Dementia
Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M., & Pearce, R. K. B. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816362aa · Cited by 145
Self-citationPathologic Correlates of Dementia in Parkinson's Disease
Chui, H. C., Mortimer, J. A., Slager, U. T., Zarow, C., Bondareff, W., & Webster, D. D. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520100013007 · Cited by 142
Tagliavini, F., & Pilleri, G. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90203-4 · Cited by 140
García‐García, D., Clavero, P., Gasca‐Salas, C., Lamet, I., Arbizu, J., Gonzalez-Redondo, R., Obeso, J. A., & Rodríguez-Oroz, M. C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2198-5 · Cited by 139
Zur pathologischen Anatomie der Paralysis agitans
Fünfgeld, E. W. (1923) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02869021 · Cited by 135
Saper, C. B., & Chelimsky, T. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90286-0 · Cited by 131
The human basal forebrain. Part II
Heimer, L., de Olmos, J. S., Alheid, G. F., Pearson, J., Sakamoto, N., Shinoda, K., Marksteiner, J., & Switzer, R. C. (1999) · Handbook of Chemical Neuroanatomy · doi:10.1016/s0924-8196(99)80024-4 · Cited by 125
Advances in non-dopaminergic treatments for Parkinson's disease
Stayte, S., & Vissel, B. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00113 · Cited by 125
Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB)
Imamura, T., Ishii, K., Hirono, N., Hashimoto, M., Tanimukai, S., Kazuai, H., Hanihara, T., Sasaki, M., & Mori, E. (1999) · Neuroreport · doi:10.1097/00001756-199906230-00020 · Cited by 123
Can Parkinson's disease pathology be propagated from one neuron to another?
Dunning, C. J. R., Reyes, J. F., Steiner, J. A., & Brundin, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.11.003 · Cited by 121
Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease
Halliday, G. M., Song, Y. J. C., & Harding, A. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0641-6 · Cited by 103
Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease
Rinne, J. O., Paljärvi, L., & Rinne, U. K. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90260-7 · Cited by 102
THALAMIC NUCLEI OF PITHECUS (MACACUS) RHESUS: I. VENTRAL THALAMUS
Papez, J. W. (1934) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1934.02250070007001 · Cited by 94
Allen, S. J., Dawbarn, D., & Wilcock, G. (1988) · Brain Research · doi:10.1016/0006-8993(88)90827-x · Cited by 88
The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
Wilcock, G. K., Esiri, M. M., Bowen, D. M., & Hughes, A. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.842 · Cited by 87
The basal nucleus of Meynert in idiopathic Parkinson's disease
Tagliavini, F., Pilleri, G., Bouras, C., & Constantinidis, J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb00798.x · Cited by 82
Kalaitzakis, M. E., Walls, A. J., Pearce, R. K. B., & Gentleman, S. M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.005 · Cited by 72
Self-citationFujishiro, H., Umegaki, H., Isojima, D., Akatsu, H., Iguchi, A., & Kosaka, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0004-1 · Cited by 70
Nagai, T., Pearson, T. W., Peng, F., McGeer, E. G., & McGeer, P. L. (1983) · Brain Research · doi:10.1016/0006-8993(83)90346-3 · Cited by 69
Cell Loss from the Nucleus Basalis of Meynert in Alzheimer's Disease
Doucette, R., Fisman, M., Hachinski, V. C., & Mersky, H. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037070 · Cited by 67
Siˇmić, G., Mrzljak, L., Fucic, A., Winblad, B. G., Lovrić, H., & Kostović, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00304-2 · Cited by 66
Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia
Iráizoz, I., Guijarro, J. L., Gonzalo, L. M., & Lacalle, S. D. (1999) · Acta Neuropathologica · doi:10.1007/s004010051068 · Cited by 62
Cullen, K. M., & Halliday, G. M. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00066-9 · Cited by 59
Iráizoz, I., Lacalle, S. D., & Gonzalo, L. M. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90198-w · Cited by 54
Comparative analysis of the nucleus basalis of Meynert among primates
Raghanti, M. A., Šimić, G., Watson, S., Stimpson, C. D., Hof, P. R., & Sherwood, C. C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.008 · Cited by 41
Subcortical Dementia: A Neurobehavioral Approach
Darvesh, S., & Freedman, M. (1996) · Brain and Cognition · doi:10.1006/brcg.1996.0043 · Cited by 37
Neuropathological changes in the nucleus basalis in schizophrenia
Williams, M. R., Marsh, R., Macdonald, C., Jain, J., Pearce, R. K. B., Hirsch, S. R., Ansorge, O., Gentleman, S., & Maier, M. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0387-7 · Cited by 36
Self-citationThalamic Nuclei of Pithecus (Macacus) Rhesus
Aronson, L. R., & Papez, J. W. (1935) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-193503000-00021 · Cited by 29
Kim, H. J., Lee, J. E., Shin, S. J., Sohn, Y. H., & Lee, P. H. (2011) · Journal of Movement Disorders · doi:10.14802/jmd.11014 · Cited by 28
Nucleus subputaminalis: neglected part of the basal nucleus of Meynert
Boban, M., Kostović, I., & Šimić, G. (2006) · Brain · doi:10.1093/brain/awl025 · Cited by 23
Schiller, F. (2000) · Journal of the History of the Neurosciences · doi:10.1076/0964-704x(200008)9:2;1-y;ft148 · Cited by 21
F. H. Lewy on Lewy bodies, parkinsonism and dementia
Föorstl, H., & Levy, R. (1991) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930061102 · Cited by 20
Nucleus basalis neuronal loss and neuritic plaques in advanced Alzheimer's disease
Etienne, P. E., Robitaille, Y., Gauthier, S. G., & Nair, N. P. V. (1986) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y86-052 · Cited by 16
Waldvogel (1999) · doi:10.1002/1531-8249(199907)46:1
Cited by
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 525
The Glymphatic System: A Novel Component of Fundamental Neurobiology
Hablitz, L. M., & Nedergaard, M. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.0619-21.2021 · Cited by 453
Alves, P. N., Foulon, C., Karolis, V., Bzdok, D., Margulies, D. S., Volle, E., & Thiebaut de Schotten, M. (2019) · Communications Biology · doi:10.1038/s42003-019-0611-3 · Cited by 357
The Mechanisms of Action of Curcumin in Alzheimer’s Disease
Tang, M., & Taghibiglou, C. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170188 · Cited by 304
Metadata
- Authors
- Liu, A. K. L., Chang, R. C.-C., Pearce, R. K. B., & Gentleman, S. M.
- Venue
- Acta Neuropathologica
- Published
- 2015-01-30
- Volume
- 129
- Issue
- 4
- Pages
- 527-540
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2042250149
- Cited by
- 368
- References
- 99
- FWCI
- 19.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.